This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pregnancy and visual changes

Authoring team

Physiological changes:

  • changes in spectacle prescription/difficulty wearing contact lenses
    • reduced production of tear fluid occurs in pregnancy
      • increased myopia (shortsightedness) occurs in about 14% of women
        • caused by reduced tear fluid, altered corneal curvature, increased corneal thickness, and influx of water into the lens
        • refraction disorders are marked by myopization, often not very significant and always regressive within six weeks after the childbirth (2)
      • also changes in tear fluid production may cause contact lens intolerance

  • subconjunctival hemorrhage may occur in about 10% of women during and after delivery
    • requires no measures other than check of blood pressure and baseline blood tests (FBC, clotting)

  • intraocular pressure decreases mildly during pregnancy
    • by 2-3 mmHg, under the influence of hormones (mainly progesterone)
    • no physiological, funduscopically visible changes of the retina arise in the course of a normal pregnancy

Pathological ocular changes:

  • ptosis
    • very rare - a few cases of ptosis due to hormonally induced weakening of the attachment of the levator palpebrae have been described
      • benign
      • change must be distinguished from an oculomotor nerve palsy (in which ptosis is accompanied by extraocular muscle weakness leading to diplopia, and by enlargement of the pupil), which requires a further neurological work-up

  • Horner's syndrome (reversible)
    • reported to arise after epidural anesthesia in 0.4% to 2.5% of cases

  • facial nerve palsy
    • probability of development of a transient facial nerve palsy during pregnancy is 38-45 per 100 000 births, or three times higher than at other times

  • central serous chorioretinopathy
    • idiopathic condition involving central retinal detachment
    • arises in 0.008% (4 of 17 000) women in the course of an otherwise unremarkable pregnancy
    • high cortisol concentration during pregnancy is thought to be the main precipitant of this condition
    • usually arises in the third trimester and regresses spontaneously a few weeks to months after delivery

  • hypertensive retinopathy and visual changes in pre-eclampsia/eclampsia
    • pregnancy-related hypertension arises in 5% to 11% of pregnant women
      • 40% to 100% of these patients show signs of hypertensive retinopathy
      • ranging from mild focal retinal vascular spasm to cotton-wool spots and hemorrhages to papilloedema
        • changes, when detected, should prompt further diagnostic and therapeutic steps, even though only 25% to 50% of the affected women are symptomatic (blurred vision, photopsia, visual field defects)
        • retinal changes reflect the severity of hypertension:
          • the most severe changes are seen in (pre-)eclampsia, ranging to reversible serous retinal detachment
        • severe vascular changes in eclampsia, leading to anterior ischemic optic neuropathy (AION) or cortical blindness, are rare
          • cortical blindness and other visual changes resulting from eclampsia may occur
          • generally resolve within hours or days, although subjective visual impairment persists in rare cases

Notes:

  • because of pregnancy related changes in the corneal curvature and thickness, refractive surgery should not be performed during pregnancy or in the first year after delivery

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.